Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-02-16 00:00:00 ET · period of report 2023-02-14 · accession 0001209191-23-010050 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-16 | 2023-02-14 | VRTX | Arbuckle Stuart A | EVP, COO | S - Sale | $298.68 | -6,398 | 79.7K | -7% | -$1.91M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-14 | S | D | 800 | $295.84 | 81,203 | D | — | — | (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F3) Open market sales reported on this line occurred at a weighted average price of $295.84 (range $295.34 to $296.20). |
| 2 | Common | Common Stock | 2023-02-14 | S | D | 901 | $296.85 | 80,302 | D | — | — | (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $296.85 (range $296.49 to $297.30). |
| 3 | Common | Common Stock | 2023-02-14 | S | D | 400 | $300.89 | 75,605 | D | — | — | (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F8) Open market sales reported on this line occurred at a weighted average price of $300.89 (range $300.78 to $301.03). |
| 4 | Common | Common Stock | 2023-02-14 | S | D | 2,003 | $299.13 | 77,739 | D | — | — | (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F6) Open market sales reported on this line occurred at a weighted average price of $299.13 (range $298.68 to $299.60). |
| 5 | Common | Common Stock | 2023-02-14 | S | D | 1,734 | $300.09 | 76,005 | D | — | — | (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F7) Open market sales reported on this line occurred at a weighted average price of $300.09 (range $299.73 to $300.70). |
| 6 | Common | Common Stock | 2023-02-14 | S | D | 560 | $298.14 | 79,742 | D | — | — | (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $298.14 (range $297.59 to $298.57). |